Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach

Julie Talon, Mirella Salvatore, Robert E. O’Neill, Yurie Nakaya, Hongyong Zheng, Thomas Muster, Adolfo García‐Sastre, Peter Palese

Proceedings of the National Academy of Sciences · 2000 · 319 citations · 29 references

Concepts

Abstract

We propose a rational approach to the generation of live viral vaccines: alteration of virally encoded type I IFN antagonists to attenuate virulence while retaining immunogenicity. We have explored this concept by using the influenza virus. Previously we have shown that the NS1 protein of influenza A virus possesses anti-IFN activity. We now present evidence that influenza A and B viruses encoding altered viral NS1 proteins are highly attenuated in the mouse host, yet provide protection from challenge with wild-type viruses.

References

29